Yichang HEC ChangJiang Pharmaceutical Co (HKSE:01558) EV-to-EBIT : 4.50 (As of May. 15, 2024)

Yichang HEC ChangJiang Pharmaceutical Co EV-to-EBIT Chart

Yichang HEC ChangJiang Pharmaceutical Co Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT		Get a 7-Day Free Trial					7.41	6.18	-15.73	24.65	3.64

Yichang HEC ChangJiang Pharmaceutical Co Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial														-15.73	-	24.65	-	3.64

Competitive Comparison of Yichang HEC ChangJiang Pharmaceutical Co's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Yichang HEC ChangJiang Pharmaceutical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yichang HEC ChangJiang Pharmaceutical Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yichang HEC ChangJiang Pharmaceutical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Yichang HEC ChangJiang Pharmaceutical Co's EV-to-EBIT falls into.

Yichang HEC ChangJiang Pharmaceutical Co EV-to-EBIT Calculation

Yichang HEC ChangJiang Pharmaceutical Co's EV-to-EBIT for today is calculated as:

Yichang HEC ChangJiang Pharmaceutical Co's current Enterprise Value is HK$11,588 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yichang HEC ChangJiang Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$2,575 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yichang HEC ChangJiang Pharmaceutical Co  (HKSE:01558) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Yichang HEC ChangJiang Pharmaceutical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Yichang HEC ChangJiang Pharmaceutical Co's Enterprise Value for the quarter that ended in Dec. 2023 was HK$9,373 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yichang HEC ChangJiang Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$2,575 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yichang HEC ChangJiang Pharmaceutical Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Yichang HEC ChangJiang Pharmaceutical Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Yichang HEC ChangJiang Pharmaceutical Co (HKSE:01558) Business Description